Clinical Trial Update: Intravenous Immunoglobulins in Severe and Refractory Solar Urticaria [Phase 2]

View source ↗

Summary

A Phase 2 study of intravenous immunoglobulins for severe and refractory solar urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solar Urticaria

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Solar Urticaria | Phase 2 | Status: COMPLETED